Celgene Corp  CELG
 Performance   more  
Growth of $10,00008-21-14
Total Return%201120122013YTD
 Stock14.316.1115.38.5
 +/- Industry2.7-18.056.5-11.7
 +/- S&P 50014.32.785.70.7
 
 Key Stats   
Last Close (08-21-14)$91.66
Market Cap $Mil73,283
Sales $Mil7,033
Morningstar Style Box Large Growth
Industry Biotechnology
Sector Healthcare
Stock Type  Aggressive Growth
Morningstar Stock Grades
Growth B
Profitability C
Financial Health B
 Valuation   more  08-21-14 
StockIndustryS&P 500
Price/Earnings53.259.519.3
Forward P/E18.6---17.6
Price/Book15.18.22.8
Price/Cash Flow35.520.511.2
Price/Sales11.18.91.8
Dividend Yield %------1.8
S&P 500 data through 08-21-14
 Growth   more  12-31-13 
1 Year%
3 Year%
S&P 500
Sales17.921.49.2
Net Income-0.418.112.0
EPS2.121.512.5
Equity/Share0.62.410.4
Dividends------19.5
S&P 500 data - 3 Year%
 Profitability   more  06-30-14 
StockIndustryS&P 500
ROA %10.66.28.4
ROE %28.613.222.3
  Net Margin %20.812.914.4
  Asset Turnover0.50.50.8
  Fin Leverage2.36.7
Sales/Employee
$Thousands
1379.0------
Stock uses trailing 12 months. Industry and S&P 500 use fiscal year-end.
 Earnings Trends   more  06-30-14 
Historical years use fiscal year-end.
 Fund Ownership  more  
 % Shares Held % Fund Assets Star Rating
Janus Twenty D 1.85 6.37 4 stars
American Funds Growth Fund of Amer A 1.60 0.40 3 stars
Vanguard Total Stock Mkt Idx 1.23 0.22 Not Rated
Vanguard US Total Market Shares (AU) ETF 1.28 0.19 Not Rated
PowerShares QQQ 1.13 1.01 5 stars
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2014 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.